These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 9804132)
1. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132 [TBL] [Abstract][Full Text] [Related]
2. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation. Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081 [TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice. Saha B; Nandi D Hepatology; 2009 Nov; 50(5):1547-57. PubMed ID: 19739265 [TBL] [Abstract][Full Text] [Related]
4. Effect of inhibition of inflammatory mediators on trauma-induced stromal edema. Karon MD; Klyce SD Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2507-11. PubMed ID: 12766049 [TBL] [Abstract][Full Text] [Related]
5. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis. Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944 [TBL] [Abstract][Full Text] [Related]
6. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells. Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258 [TBL] [Abstract][Full Text] [Related]
7. Topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation. Shi H; Yu HJ; Wang HY; Wang WT; Jin SH; Zhu P; Li SJ; Rong CT; Li JY Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8016-28. PubMed ID: 23139277 [TBL] [Abstract][Full Text] [Related]
8. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells. Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030 [TBL] [Abstract][Full Text] [Related]
9. Chemopreventive efficacy of promising farnesyltransferase inhibitors. Lantry LE; Zhang Z; Crist KA; Wang Y; Hara M; Zeeck A; Lubet RA; You M Exp Lung Res; 2000 Dec; 26(8):773-90. PubMed ID: 11195470 [TBL] [Abstract][Full Text] [Related]
10. TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits. Kim JA; Ko JH; Ko AY; Lee HJ; Kim MK; Wee WR; Lee RH; Fulcher SF; Oh JY Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4905-12. PubMed ID: 25034606 [TBL] [Abstract][Full Text] [Related]
11. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Hara M; Han M Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3333-7. PubMed ID: 7536929 [TBL] [Abstract][Full Text] [Related]
12. Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice. Oshima T; Sonoda KH; Tsutsumi-Miyahara C; Qiao H; Hisatomi T; Nakao S; Hamano S; Egashira K; Charo IF; Ishibashi T Br J Ophthalmol; 2006 Feb; 90(2):218-22. PubMed ID: 16424537 [TBL] [Abstract][Full Text] [Related]
13. Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells. Zhou JM; Zhu XF; Pan QC; Liao DF; Li ZM; Liu ZC Int J Mol Med; 2003 Jun; 11(6):767-71. PubMed ID: 12736720 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin. Kainuma O; Asano T; Hasegawa M; Kenmochi T; Nakagohri T; Tokoro Y; Isono K Pancreas; 1997 Nov; 15(4):379-83. PubMed ID: 9361092 [TBL] [Abstract][Full Text] [Related]
15. Involvement of macrophage chemotactic protein-1 and interleukin-1beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea. Yoshida S; Yoshida A; Matsui H; Takada Y; Ishibashi T Lab Invest; 2003 Jul; 83(7):927-38. PubMed ID: 12861033 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment. Bignami F; Lorusso A; Rama P; Ferrari G Acta Ophthalmol; 2017 Nov; 95(7):e641-e648. PubMed ID: 28205389 [TBL] [Abstract][Full Text] [Related]
19. Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor. Park D; Pandey SK; Maksimova E; Kole S; Bernier M Biochemistry; 2000 Oct; 39(41):12513-21. PubMed ID: 11027130 [TBL] [Abstract][Full Text] [Related]
20. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]